Immunology Activities
Influenza Treatment: Exploring the Clinical and Economic Benefits of Antivirals
0290-0000-20-142-H01-P
This activity will distinguish the patient populations at high risk for influenza-related complications.
1.50
Primary Immunodeficiency Disorder: Considerations in the Use of Intravenous and Subcutaneous Immunoglobulin
0290-0000-20-132-H01-P
This activity will provide practice pearls for specialty pharmacists to improve care for those affected by PID.
1.50
Reviewing Interleukin 17— and Interleukin 23—targeting Therapies and Best Practices in Psoriatic Disease Management Feat. Clinical Practice Video Vignettes
0290-0000-20-043-H01-P
This activity includes patient counseling videos that highlight the vital roles of specialty pharmacists in assisting patients with PsO and PsA via clinical interventions, educating patients about administration, and monitoring patient response and adherence to selected therapy.
2.00
Improving the Economic Burden of Ankylosing Spondylitis: Targeting IL-17/IL-23 Pathways
0290-0000-19-159-H01-P
This 2-part supplement will analyze ankylosing spondylitis pathophysiology, associated comorbidities, classification, and early diagnosis.
2.00